Management
Proniras has assembled a seasoned management team, board of directors, and key product development experts that understand well the challenges associated with the development of new treatments for substance use and specialty central nervous system (CNS) disorders.
OPERATING TEAM

Andrew Chambers, MD
Addiction Psychiatry
PI for first clinical trial

Greg Coulter, Ph.D.
Drug Substance/Drug Product

Gregory Dietsch, PhD, DABT
Toxicology and Pharmacokinetics

Ken Ferguson, Ph.D.
Development

Michelle Rose, Ph.D.
Regulatory

Keri Urwin, MBA
Clinical Operations

Michelle Woods
Quality